Inquiry

Saatja: "Janne Sepp" <[email protected]> Saaja: "Kärolin Jenas" <[email protected]> Teema: Ed: OECD Health Statistic Inquiry Kuupäev: 2025-01-14 10:09 Saatja: [email protected] <[email protected]> Saatmisaeg: esmaspäev, 6. jaanuar 2025 13:24 Adressaat: Janne Sepp <[email protected]> Teema: RE: OECD Health Statistic Inquiry Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Hi Janne, Hope you had a wonderful holiday season! Many thanks for your guidance on this matter, it is very helpful. I was wondering if it would be possible to receive similar reports to “DDD 2023 ENG.pdf” for previous years so we are able to create a time series? I wish you a wonderful start to the new year! Best, Sophie Restricted Use - À usage restreint From: Janne Sepp <[email protected] <mailto:[email protected]> > Sent: Monday, December 9, 2024 9:54 AM To: WANG Sophie, ELS/HD <[email protected] <mailto:[email protected]> > Subject: Vs: OECD Health Statistic Inquiry Dear Sophie, Thank you for your e-mail and apologizes for the delay in answering. In Estonia the consumption of ATC N01 group (anesthetics) is collected at the national level (wholesale data). You can find a more detailed information on our website: https://ravimiamet.ee/en/statistics/statistics-medicines On the same page there is a data table (named “DDD 2023 ENG.pdf”) on active substance level, covering also N01 units: https://ravimiamet.ee/sites/default/files/documents/2024-04/DDD%202023%20E NG.pdf Kind regards, Janne Sepp State Agency of Medicines Department of Post-Authorisation Safety Bureau of Drug Statistics Specialist Phone: +372 737 4140 <mailto:[email protected]> [email protected] Nooruse 1, 50411 Tartu, Estonia <http://www.ravimiamet.ee/> www.ravimiamet.ee This e-mail and any attachments transmitted may contain confidential and privileged information. If you are not the intended recipient, please notify the sender immediately by returning the e-mail and permanently deleting what you have recieved. Any dissemination or use of this information by a third person without permission is prohibited and may be illegaal. Restricted Use - À usage restreint From: [email protected] <mailto:[email protected]> <[email protected] <mailto:[email protected]> > Sent: esmaspäev, 25. november 2024 10:59 To: Ravimiamet <[email protected] <mailto:[email protected]> > Subject: OECD Health Statistic Inquiry Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Hello, Pleased to e-meet you. I am from OECD Health working on climate and health issues. I am quite interested in the database of medicine statistics provided here: PxWeb - Select table <https://statistika.tai.ee/pxweb/en/Andmebaas/Andmebaas__06Ravimistatistik a__01Ravimistatistika/?tablelist=true> . We are currently in the process of looking at anesthetic gas volumes consumed in countries and wanted to inquire about whether if consumption of ATC N01 group (anesthetics) is collected at the national level? And if so, at what unit is this data collected? Many thanks, Sophie Sophie Wang, PhD Health Policy Researcher, Health Division Directorate for Employment, Labour, and Social Affairs 2, rue André Pascal – 75775 Paris Cedex 16 [email protected] <mailto:[email protected]> | Tel: +33 1 85 55 49 44 This communication is intended only for the use of the individual or entity to whom it is addressed and others authorised by the sender to receive it. Any unauthorised disclosure, use, or publication of this information is not allowed. If you have received this communication in error, please notify the sender immediately and delete it from your system. Cette communication est uniquement destinée à la personne ou à l’entité à laquelle elle est adressée et à d’autres autorisées par l’émetteur à la recevoir. Aucune divulgation, utilisation ou publication de ces informations n’est autorisée. Si vous avez reçu cette communication par erreur, veuillez en notifier l’émetteur immédiatement et la détruire de votre système. Restricted Use - À usage restreint This communication is intended only for the use of the individual or entity to whom it is addressed and others authorised by the sender to receive it. Any unauthorised disclosure, use, or publication of this information is not allowed. If you have received this communication in error, please notify the sender immediately and delete it from your system. Cette communication est uniquement destinée à la personne ou à l’entité à laquelle elle est adressée et à d’autres autorisées par l’émetteur à la recevoir. Aucune divulgation, utilisation ou publication de ces informations n’est autorisée. Si vous avez reçu cette communication par erreur, veuillez en notifier l’émetteur immédiatement et la détruire de votre système.